Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 35

Sort by

Sort Order Select

Journal Articles

Mesenchymal stromal cells orchestrate follicular lymphoma cell niche through the CCL2-dependent recruitment and polarization of monocytes

Fabien Guilloton, Gersende Caron, Cédric Ménard, Céline Pangault, Patricia Amé-Thomas, Joëlle Dulong, John De Vos, Delphine Rossille, Catherine Henry, Thierry Lamy, Olivier Fouquet, Thierry Fest, Karin Tarte

Blood (2012) 119 (11): 2556–2567.

https://doi.org/10.1182/blood-2011-08-370908

Published: 2012

Includes: Supplemental data

Journal Articles

Mesenchymal Stromal Cells Orchestrate Follicular Lymphoma Cell Niche Through the CCL2-Dependent Recruitment and Polarization of Monocytes

Fabien Guilloton, Gersende Caron, Cédric Ménard, Céline Pangault, PharmD, PhD, Patricia Amé-Thomas, Joelle Dulong, John De Vos, Delphine Rossille, PhD, Thierry Lamy, MD, PhD, Thierry Fest, Karin Tarte

Blood (2011) 118 (21): 1566.

https://doi.org/10.1182/blood.V118.21.1566.1566

Published: 2011

Journal Articles

An in vitro model of differentiation of memory B cells into plasmablasts and plasma cells including detailed phenotypic and molecular characterization

Michel Jourdan, Anouk Caraux, John De Vos, Geneviève Fiol, Marion Larroque, Chantal Cognot, Caroline Bret, Christophe Duperray, Dirk Hose, Bernard Klein

Blood (2009) 114 (25): 5173–5181.

https://doi.org/10.1182/blood-2009-07-235960

Published: 2009

Includes: Supplemental data

Journal Articles

Follicular Lymphoma Cell Niche: Identification of a Preeminent IL-4-Dependent T FH - B Cell Axis.

Karin Tarte, PhD, Pangault Celine, PhD, Patricia Ame-Thomas, PhD, Philippe Ruminy, PhD, Delphine Rossille, Gersende Caron, PhD, Maryse Bahia, John De Vos, MD, PhD, Mikael Roussel, MD, PhD, Celine Monvoisin, Thierry Lamy, MD, PhD, Philippe Gaulard, MD, Herve Tilly, MD, Thierry Fest, MD, PhD

Blood (2009) 114 (22): 757.

https://doi.org/10.1182/blood.V114.22.757.757

Published: 2009

Journal Articles

An in Vitro Model of Differentiation of Memory B Cells Into Plasmablasts and Plasma Cells Including Detailed Phenotypic and Molecular Characterization.

Michel Jourdan, Anouk Caraux, John De Vos, PhD, Geneviève Fiol, Marion Larroque, Chantal Cognot, Caroline Bret, Christophe Duperray, Dirk Hose, Bernard Klein

Blood (2009) 114 (22): 1636.

https://doi.org/10.1182/blood.V114.22.1636.1636

Published: 2009

Journal Articles

Induction of angiogenesis by normal and malignant plasma cells

Dirk Hose, Jérôme Moreaux, Tobias Meissner, Anja Seckinger, Hartmut Goldschmidt, Axel Benner, Karène Mahtouk, Jens Hillengass, Thierry Rème, John De Vos, Michael Hundemer, Maud Condomines, Uta Bertsch, Jean-François Rossi, Anna Jauch, Bernard Klein, Thomas Möhler

Blood (2009) 114 (1): 128–143.

https://doi.org/10.1182/blood-2008-10-184226

Published: 2009

Includes: Supplemental data

Journal Articles

Inhibition of aurora kinases for tailored risk-adapted treatment of multiple myeloma

Blood (2009) 113 (18): 4331–4340.

https://doi.org/10.1182/blood-2008-09-178350

Published: 2009

Includes: Supplemental data

Journal Articles

C/EBPA methylation is common in T-ALL but not in M0 AML

Louis Terriou, Raouf Ben Abdelali, Christophe Roumier, Ludovic Lhermitte, John de Vos, Pascale Cornillet, Olivier Nibourel, Kheira Beldjord, Hervé Dombret, Guy Leverger, Vahid Asnafi, Claude Preudhomme, Elizabeth Macintyre

Blood (2009) 113 (8): 1864–1866.

https://doi.org/10.1182/blood-2008-09-176909

Published: 2009

Journal Articles

The Clinical Utility of Microarray-Based Gene Expression Profiling in the Diagnosis and Sub-Classification of Leukemia: Final Report on 3252 Cases from the International MILE Study Group

Blood (2008) 112 (11): 753.

https://doi.org/10.1182/blood.V112.11.753.753

Published: 2008

Journal Articles

Osteoclast Gene Expression Profiling in Multiple Myeloma

Jerome Moreaux, Dirk Hose, Thierry Rème, Philippe Moine, Karène Mahtouk, Marion Moos, Guilhem Requirand, John De Vos, PhD, Jean François Rossi, Hartmut Goldschmidt, Bernard Klein

Blood (2008) 112 (11): 2735.

https://doi.org/10.1182/blood.V112.11.2735.2735

Published: 2008

Journal Articles

Bone Morphogenic Protein 6: A Prognostic Factor Expressed by Normal Plasma Cells and Multiple Myeloma Cells Inhibiting Their Proliferation and Angiogenesis Induction

Anja Seckinger, Tobias Meißner, Jérôme Moreaux, Hartmut Goldschmidt, Axel Benner, Michael Hundemer, Thierry Rème, John D. Shaughnessy, Jr., Bart Barlogie, Uta Bertsch, Jens Hillengass, Anthony D. Ho, Véronique Pantesco, Anna Jauch, John De Vos, Jean François Rossi, Thomas Möhler, Bernard Klein, Dirk Hose

Blood (2008) 112 (11): 2701.

https://doi.org/10.1182/blood.V112.11.2701.2701

Published: 2008

Journal Articles

Inhibition of Aurora-Kinases for Tailored Risk-Adapted Treatment of Multiple Myeloma

Blood (2008) 112 (11): 248.

https://doi.org/10.1182/blood.V112.11.248.248

Published: 2008

Journal Articles

Trisomy 13, AML1 Mutations and M0 Subtype Are Remarkably Intricate Events in Acute Myeloid Leukemia (AML).

Olivier Nibourel, Christophe Roumier, Nathalie Philippe, Sabine Quief, Celine Villenet, Jean-Luc Laï, Nicole Dastugue, Isabelle Tigaud, John de Vos, Jean Soulier, Antonio Alberdi, Daniela Geromin, Eric Delabesse, Jean-Pierre Kerckaert, Claude Preudhomme

Blood (2007) 110 (11): 4250.

https://doi.org/10.1182/blood.V110.11.4250.4250

Published: 2007

Journal Articles

An International Multi-Center Study To Define the Application of Microarray-Based Gene Expression Profiling in the Diagnosis and Sub-Classification of Leukemia (MILE Study): Analysis of Completed Stage I with 2030 Patients Achieved a 95.4% Accuracy.

Blood (2007) 110 (11): 3169.

https://doi.org/10.1182/blood.V110.11.3169.3169

Published: 2007

Journal Articles

Gene Expression Profiling of Myeloma Cells To Predict Response to Primary Therapy with Thalidomide-Dexamethasone for Newly Diagnosed Multilple Myeloma.

Abderrahman Abdelkefi, MD, John de Vos, M.D, Said Assou, M.D, Tarek Ben Othman, M.D, Jean-Francois Rossi, M.D, Saloua Ladeb, M.D, Ines Safra, M.D, Yosr Galai, M.D, Malika Ben Ahmed, M.D, Alia Benkahla, M.D, Faouzi Jenhani, M.D, Moufida Ben Nasr, M.D, Lamia Torjman, M.D, Amel Lakhal, M.D, Hechmi Louzir, M.D, Abdeladhim Ben Abdeladhim, M.D

Blood (2007) 110 (11): 1494.

https://doi.org/10.1182/blood.V110.11.1494.1494

Published: 2007

Journal Articles

Gene Expression Profiling and Real-Time PCR Analyses Make It Possible To Identify Novel Potential Cancer-Testis Antigens in Multiple Myeloma.

Maud Condomines, PhD, Dirk Hose, PhD, MD, Thierry Reme, PhD, John de Vos, PhD, MD, Guilhem Requirand, Jean-Francois Rossi, PhD, MD, Hartmunt Goldschmidt, PhD, MD, Bernard Klein

Blood (2007) 110 (11): 1793.

https://doi.org/10.1182/blood.V110.11.1793.1793

Published: 2007

Journal Articles

Gene Expression Profiling of Highly Purified Malignant and Non-Malignant Cells: Characterization of the Tumor-Microenvironment Cellular Synapse in De Novo Follicular Lymphoma (FL).

Karin Tarte, PhD, Céline Pangault, PhD, John de Vos, MD, PhD, Philippe Ruminy, PhD, Fabienne Sauvee, Patrick Tas, MD, Jean-Michel Picquenot, MD, Hervé Tilly, MD, PhD, Thierry Lamy, MD, PhD, Christian Bastard, MD, PhD, Thierry Fest, MD, PhD

Blood (2007) 110 (11): 355.

https://doi.org/10.1182/blood.V110.11.355.355

Published: 2007

Journal Articles

Heparanase influences expression and shedding of syndecan-1, and its expression by the bone marrow environment is a bad prognostic factor in multiple myeloma

Karène Mahtouk, Dirk Hose, Pierre Raynaud, Michael Hundemer, Michel Jourdan, Eric Jourdan, Veronique Pantesco, Marion Baudard, John De Vos, Marion Larroque, Thomas Moehler, Jean-Francois Rossi, Thierry Rème, Hartmut Goldschmidt, Bernard Klein

Blood (2007) 109 (11): 4914–4923.

https://doi.org/10.1182/blood-2006-08-043232

Published: 2007

Journal Articles

CD200 is a new prognostic factor in multiple myeloma

Jerome Moreaux, Dirk Hose, Thierry Reme, Eric Jourdan, Michael Hundemer, Eric Legouffe, Philippe Moine, Philippe Bourin, Marion Moos, Jill Corre, Thomas Möhler, John De Vos, Jean Francois Rossi, Hartmut Goldschmidt, Bernard Klein

Blood (2006) 108 (13): 4194–4197.

https://doi.org/10.1182/blood-2006-06-029355

Published: 2006

Includes: Supplemental data

Journal Articles

An International Multi-Center Study To Define the Application of Microarrays in the Diagnosis and Subclassification of Leukemia (MILE Study): Interim Analysis Based on 1,889 Patients Achieves 95.4% Prediction Accuracy.

Blood (2006) 108 (11): 103.

https://doi.org/10.1182/blood.V108.11.103.103

Published: 2006

NARROW

Mesenchymal stromal cells orchestrate follicular lymphoma cell niche through the CCL2-dependent recruitment and polarization of monocytes

Mesenchymal Stromal Cells Orchestrate Follicular Lymphoma Cell Niche Through the CCL2-Dependent Recruitment and Polarization of Monocytes

An in vitro model of differentiation of memory B cells into plasmablasts and plasma cells including detailed phenotypic and molecular characterization

Follicular Lymphoma Cell Niche: Identification of a Preeminent IL-4-Dependent T FH - B Cell Axis.

An in Vitro Model of Differentiation of Memory B Cells Into Plasmablasts and Plasma Cells Including Detailed Phenotypic and Molecular Characterization.

Induction of angiogenesis by normal and malignant plasma cells

Inhibition of aurora kinases for tailored risk-adapted treatment of multiple myeloma

C/EBPA methylation is common in T-ALL but not in M0 AML

The Clinical Utility of Microarray-Based Gene Expression Profiling in the Diagnosis and Sub-Classification of Leukemia: Final Report on 3252 Cases from the International MILE Study Group

Osteoclast Gene Expression Profiling in Multiple Myeloma

Bone Morphogenic Protein 6: A Prognostic Factor Expressed by Normal Plasma Cells and Multiple Myeloma Cells Inhibiting Their Proliferation and Angiogenesis Induction

Inhibition of Aurora-Kinases for Tailored Risk-Adapted Treatment of Multiple Myeloma

Trisomy 13, AML1 Mutations and M0 Subtype Are Remarkably Intricate Events in Acute Myeloid Leukemia (AML).

An International Multi-Center Study To Define the Application of Microarray-Based Gene Expression Profiling in the Diagnosis and Sub-Classification of Leukemia (MILE Study): Analysis of Completed Stage I with 2030 Patients Achieved a 95.4% Accuracy.

Gene Expression Profiling of Myeloma Cells To Predict Response to Primary Therapy with Thalidomide-Dexamethasone for Newly Diagnosed Multilple Myeloma.

Gene Expression Profiling and Real-Time PCR Analyses Make It Possible To Identify Novel Potential Cancer-Testis Antigens in Multiple Myeloma.

Gene Expression Profiling of Highly Purified Malignant and Non-Malignant Cells: Characterization of the Tumor-Microenvironment Cellular Synapse in De Novo Follicular Lymphoma (FL).

Heparanase influences expression and shedding of syndecan-1, and its expression by the bone marrow environment is a bad prognostic factor in multiple myeloma

CD200 is a new prognostic factor in multiple myeloma

An International Multi-Center Study To Define the Application of Microarrays in the Diagnosis and Subclassification of Leukemia (MILE Study): Interim Analysis Based on 1,889 Patients Achieves 95.4% Prediction Accuracy.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only